|
|||||
|
|
Impact of Human Immunodeficiency Virus Type 1 Resistance to Protease Inhibitors on Evolution of Resistance to the Maturation Inhibitor Bevirimat (PA-457) |
|
| Authors: | Catherine S Adamson Kayoko Waki Sherimay D Ablan Karl Salzwedel Eric O Freed |
| Institution: | Virus-Cell Interaction Section, HIV Drug Resistance Program, National Cancer Institute, Frederick, Maryland 21702-1201,1. Panacos Pharmaceuticals Inc., 209 Perry Parkway, Gaithersburg, Maryland 208772. |
| Abstract: | |
| Keywords: | |